Rapid Test and Treat Dolutegravir Plus Lamivudine Study in Newly Diagnosed Human Immunodeficiency Virus (HIV)-1 Infected Adultsmidwayadmin2019-10-28T18:51:58+00:00
Rapid Test and Treat Dolutegravir Plus Lamivudine Study in Newly Diagnosed Human Immunodeficiency Virus (HIV)-1 Infected Adults
212355 (STAT) · Trial ·
Major Inclusion/Exclusion Criteria:
- HIV Treatment Naive
- Diagnosed within 14 days prior to Screening
- No Hepatitis B infection